Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis
Open accessThe DOI matches its Crossref record; 52 of the 54 references it cites were found in a registry or an index.
Abstract
In experimental autoimmune encephalomyelitis (EAE), an animal model for multiple sclerosis (MS), loss of the blood-brain barrier (BBB) tight junction (TJ) protein claudin-3 correlates with immune cell infiltration into the CNS and BBB leakiness. Here we show that sealing BBB TJs by ectopic tetracycline-regulated expression of the TJ protein claudin-1 in Tie-2 tTA//TRE-claudin-1 double transgenic C57BL/6 mice had no influence on immune cell trafficking across the BBB during EAE and furthermore did not influence the onset and severity of the first clinical disease episode. However, expression of claudin-1 did significantly reduce BBB leakiness for both blood borne tracers and endogenous plasma proteins specifically around vessels expressing claudin-1. In addition, mice expressing claudin-1 exhibited a reduced disease burden during the chronic phase of EAE as compared to control littermates. Our study identifies BBB TJs as the critical structure regulating BBB permeability but not immune cell trafficking into CNS during EAE, and indicates BBB dysfunction is a potential key event contributing to disease burden in the chronic phase of EAE. Our observations suggest that stabilizing BBB barrier function by therapeutic targeting of TJs may be beneficial in treating MS, especially when anti-inflammatory treatments have failed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Compston, A., & Coles, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61620-7 · Cited by 4,372
Size-selective loosening of the blood-brain barrier in claudin-5–deficient mice
Nitta, T., Hata, M., Gotoh, S., Seo, Y., Sasaki, H., Hashimoto, N., Furuse, M., & Tsukita, S. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200302070 · Cited by 1,917 · cited 3×
“In addition to claudin-5 and claudin-3, expression of claudin-12 has also been described at the BBB [35].”
BackgroundKebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759
Claudin-based tight junctions are crucial for the mammalian epidermal barrier
Furuse, M., Hata, M., Furuse, K., Yoshida, Y., Haratake, A., Sugitani, Y., Noda, T., Kubo, A., & Tsukita, S. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200110122 · Cited by 1,512 · cited 1×
“This notion is supported by previous findings demonstrating that claudin-1 seals TJs in skin epithelial and lung endothelial cells [13, 14].”
ResultBlood‐brain barrier‐specific properties of a human adult brain endothelial cell line
Weksler, B. B., Subileau, E. A., Perrière, N., Charneau, P., Holloway, K., Leveque, M., Tricoire‐Leignel, H., Nicotra, A., Bourdoulous, S., Turowski, P., et al. (2005) · The FASEB Journal · doi:10.1096/fj.04-3458fje · Cited by 1,330 · cited 1×
“Later studies, however, which specifically excluded cross-reactivity of anti-claudin-1 antibodies with claudin-3 failed to detect any immunostaining for claudin-1 in CNS parenchymal microvessels or in primary mouse or human brain endothelial cells [2, 20, 43, 47].”
BackgroundComplex Phenotype of Mice Lacking Occludin, a Component of Tight Junction Strands
Saitou, M., Furuse, M., Sasaki, H., Schulzke, J.-D., Fromm, M., Takano, H., Noda, T., & Tsukita, S. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4131 · Cited by 1,195 · cited 2×
“Occludin is highly expressed in TJ of the BBB but not in endothelial TJs of non-neuronal tissues [4, 22], while intact BBB TJs can form in the absence of occludin in vivo [38].”
BackgroundTight junctions of the blood–brain barrier
Wolburg, H., & Lippoldt, A. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00200-8 · Cited by 1,183
Furuse, M., Sasaki, H., Fujimoto, K., & Tsukita, S. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.143.2.391 · Cited by 965 · cited 2×
“In contrast to occludin, claudins have been shown to be sufficient to induce TJ strands when transfected into fibroblasts [15].”
BackgroundMorita, K., Sasaki, H., Furuse, M., & Tsukita, S. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.147.1.185 · Cited by 869 · cited 2×
“Upon transfection into fibroblasts claudin-5 induces E-face associated TJs [34], whereas claudin-3, which is specifically expressed in TJ of CNS but not other endothelial cells [44, 47], induces P-face associated TJs [16].”
BackgroundWnt/β-catenin signaling controls development of the blood–brain barrier
Liebner, S., Corada, M., Bangsow, T., Babbage, J., Taddei, A., Czupalla, C. J., Reis, M., Felici, A., Wolburg, H., Fruttiger, M., et al. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200806024 · Cited by 860
Cited by
Development, maintenance and disruption of the blood-brain barrier
Obermeier, B., Daneman, R., & Ransohoff, R. M. (2013) · Nature Medicine · doi:10.1038/nm.3407 · Cited by 2,452
Blood-Brain Barrier: From Physiology to Disease and Back
Sweeney, M. D., Zhao, Z., Montagne, A., Nelson, A. R., & Zlokovic, B. V. (2019) · Physiological Reviews · doi:10.1152/physrev.00050.2017 · Cited by 2,312
Capture, crawl, cross: the T cell code to breach the blood–brain barriers
Engelhardt, B., & Ransohoff, R. M. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.07.004 · Cited by 686
Self-citationBrain barriers: Crosstalk between complex tight junctions and adherens junctions
Tietz, S., & Engelhardt, B. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201412147 · Cited by 551
“Using the EAE model, a critical function for BBB TJs in maintaining barrier functions of the BBB in neuroinflammation has been further supported by the observation that inducible endothelial cell–specific ectopic expression of claudin-1 ameliorated clinical symptoms of EAE in mice by specifically blocking BBB leakines…”
BackgroundInfluentialSelf-citationJunctional proteins of the blood-brain barrier: New insights into function and dysfunction
Stamatovic, S. M., Johnson, A. M., Keep, R. F., & Andjelkovic, A. V. (2016) · Tissue Barriers · doi:10.1080/21688370.2016.1154641 · Cited by 428
“Some other claudins, like claudin-1 and ¡12, are considered to be inducible in brain endothelial cells.(14) Claudin-1 shares a common 3D-structure with claudin-3 and 5, which involves a b-sheet comprising both extracellular segments anchored to a transmembranous 4-helix bundle.”
Background
Metadata
- Authors
- Pfeiffer, F., Schäfer, J., Lyck, R., Makrides, V., Brunner, S., Schaeren-Wiemers, N., Deutsch, U., & Engelhardt, B.
- Affiliations
- University of Bern (CH)
- University of Zurich (CH)
- University Hospital of Basel (CH)
- Corresponding author
- Engelhardt, Britta
- Venue
- Acta Neuropathologica
- Published
- 2011-10-09
- Volume
- 122
- Issue
- 5
- Pages
- 601-614
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC3207130
- OpenAlex
- W2045454822
- Cited by
- 160
- References
- 54
- Citations by year
- 2026: 2 · 2025: 17 · 2024: 6 · 2023: 7 · 2022: 10 · 2021: 8 · 2020: 12 · 2019: 9 · 2018: 11 · 2017: 15 · 2016: 12 · 2015: 11 · 2014: 15 · 2013: 11 · 2012: 12
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- Locations
- Acta Neuropathologica (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- reroDoc Digital Library (submittedVersion)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by-nc)
- Open Access CRIS of the University of Bern
- Funders
- European Commission (202213, 241861, 201024)
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- claudin-1, blood-brain barrier, tight junctions, experimental autoimmune encephalomyelitis, multiple sclerosis, blood-brain barrier permeability, immune cell trafficking, claudin-3, tetracycline-regulated gene expression, plasma protein leakage
- MeSH terms
- Animals, Blood-Brain Barrier, Cell Movement, Central Nervous System, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental, Endothelium, Vascular, Gene Expression Regulation, Membrane Proteins, Mice, Inbred C57BL, Mice, Transgenic, Multiple Sclerosis, Tetracycline, Tight Junctions, Receptor, TIE-2, Mice, Claudin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis. https://app.cochat.ai/papers/10.1007/s00401-011-0883-2
- The paper
- Pfeiffer, F., Schäfer, J., Lyck, R., Makrides, V., Brunner, S., Schaeren-Wiemers, N., Deutsch, U., & Engelhardt, B. (2011). Claudin-1 induced sealing of blood–brain barrier tight junctions ameliorates chronic experimental autoimmune encephalomyelitis. Acta Neuropathologica. https://doi.org/10.1007/s00401-011-0883-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.